Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Regeneron Pharmaceuticals has been named to the Dow Jones Best-in-Class World Index for seven consecutive years and North America Index for six years. The recognition highlights the company's commitment to sustainability, corporate responsibility, and patient access, exemplified by offering its new gene therapy for a form of genetic hearing loss fo…
LENSAR, Inc. reported its financial results for Q1 2026, highlighting a 5% decline in total revenue to $13.4 million driven by reduced system sales amid acquisition-related market uncertainty. However, recurring revenue grew 9% to $12.6 million, comprising 94% of total revenue. The company installed 7 new ALLY Robotic Cataract Laser Systems, increa…
Applied Optoelectronics, Inc. announced equity grants of 299 restricted stock units to two new employees under its 2023 Equity Inducement Plan. These awards are intended as an incentive for joining the company and will vest over four years, subject to continuous employment. The plan complies with Nasdaq rules and is designed to attract talent to su…
Ultralife Corporation reported a decline in Q1 2026 revenue and profitability due to production disruptions and weaker sales in its communications systems segment, despite achieving a record backlog of $115 million. Operational challenges included power outages and inventory integration delays, impacting manufacturing efficiency and margins. The co…
AMC Global Media Inc. reported first quarter 2026 results highlighting 11% growth in streaming revenues to $174 million, driven by price increases despite a 1% decline in streaming subscribers. Total net revenues declined 2% to $542 million. The company generated $65 million in free cash flow but posted a GAAP net loss of $18.9 million, compared to…
First Advantage Corporation, a global software and data company specializing in identity solutions and risk management, announced that its management team will participate in several upcoming investor conferences including Needham Technology, William Blair Growth Stock, Stifel Boston Cross Sector, and Baird Global Consumer, Technology & Services. T…
Artiva Biotherapeutics announced the pricing of an underwritten offering of common stock and pre-funded warrants totaling approximately $300 million gross proceeds. The capital raise aims to support clinical development, including a planned Phase 3 trial of its lead AlloNK cell therapy targeting refractory rheumatoid arthritis and other autoimmune …
ANI Pharmaceuticals announced first quarter 2026 financial results with revenue growth of 20.5% year-over-year to $237.5 million and adjusted EBITDA increase of 24.1%. Notably, Cortrophin Gel revenue rose 42.1% to $75.1 million driven by expanded sales and demand momentum. The company raised its 2026 net revenue guidance to $1.08-$1.14 billion, adj…
Acerinox is keeping open the option of listing its U.S. subsidiary on the New York Stock Exchange after completing the acquisition of Haynes International. Company leaders cite stronger U.S. valuations and liquidity, say they would retain majority control if they proceed with an IPO, and downplay fears of U.S. trade retaliation linked to Spain's st…
Global markets spent the week trading between a powerful rally in AI-related semiconductor names and sharp swings in crude driven by renewed U.S.-Iran military tensions. Bullish capex projections from major banks and robust demand for AI compute pushed chip stocks and Asian indexes higher, while oil moves, bond yields and currency intervention adde…
As first-quarter results continue to arrive, investors are rotating beyond mega-cap technology into Industrial and cyclical names that had been trading at depressed valuations. AI-powered selection models identified several stocks that rallied sharply after earnings, producing notable gains for subscribers. Two industrial-focused companies - a comm…
Brookfield Asset Management Ltd. reported robust financial results for Q1 2026, including $21 billion raised in the quarter and $67 billion year-to-date. Fee-related earnings increased 11% to $772 million for the quarter and 18% annually to $3.1 billion. The company highlights growth in infrastructure, private equity, energy, real estate, and credi…
Brookfield Business Corporation announced its financial results for Q1 2026, highlighting a 5% organic increase in adjusted EBITDA despite a 50% decline in net income per Class A share compared to the prior year. The company benefited from a $1 billion annual cash tax credit related to its Clarios advanced energy storage operation, realized a 3x re…
Castellum, Inc., a cybersecurity and electronic warfare company focused on U.S. federal government contracts, announced Q1 2026 financial results showing a 23% revenue increase year-over-year to $14.3 million, improved gross profit, reduced net loss, and a debt-free balance sheet. The company also reported a record contract backlog of $273.3 millio…
Oceaneering looks attractively valued against improving fundamentals: positive free cash flow of $238M, an EV/EBITDA of 8.96 and renewed contract momentum in defense and offshore energy. We propose a tactical long for a mid-term recovery tied to further contract awards, fleet utilization and defense program ramp.
Deutsche Bank upgraded Prysmian SpA to a 'buy' rating from 'hold' and raised its price target to €167 from €100, citing accelerating demand for fiber and medium-voltage cabling driven by artificial intelligence infrastructure requirements. The bank highlighted Prysmian's U.S. manufacturing footprint and potential long-term agreements with hyperscal…
U.S. stock index futures rose in early trading as a rebound in semiconductor shares tempered investor concern over clashes between U.S. and Iranian forces in the Gulf and firming oil prices. Market participants are braced for a closely watched Labor Department employment report due at 8:30 a.m. ET that could influence the outlook for Federal Reserv…
Rheinmetall shares tumbled after JPMorgan cut the stock to Neutral from Overweight and reduced its price target to €1,500 from €2,130, pointing to execution shortfalls and doubts about the company’s product mix. The downgrade followed a pair of quarterly misses in which sales and operating profit fell short of analyst consensus, and comes despite m…
Neutron Holdings, Inc., the operator of Lime, has submitted a registration statement to the U.S. Securities and Exchange Commission for a proposed initial public offering of common stock and plans to list on The Nasdaq Global Select Market under the symbol LIME. The filing does not specify share count or price range and the offering remains conting…
Neutron Holdings, Inc., which operates under the Lime brand, has submitted a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of common stock. The company says it is the largest global shared micromobility business and plans to list on the Nasdaq Global Select Market under the ticker sym…
Artiva Biotherapeutics announced positive initial clinical results from its AlloNK cell therapy for refractory rheumatoid arthritis (RA), showing a 71% ACR50 response rate at six months with a favorable outpatient tolerability profile. The FDA agreed on a design for a single Phase 3 registrational trial comparing AlloNK plus rituximab versus rituxi…
AirSculpt Technologies, Inc. reported flat revenue of $39.4 million and a slight increase in case volume in Q1 2026 compared to Q1 2025, with a reduced net loss of $2.4 million. The company reaffirmed its 2026 full-year revenue guidance of $151 - $157 million and adjusted EBITDA guidance of $15 - $17 million, highlighting a strengthened balance she…
Essent Group Ltd. reported net income of $171.8 million for Q1 2026, slightly down from $175.4 million in Q1 2025, with earnings per diluted share increasing to $1.82 from $1.69. The company declared a quarterly cash dividend of $0.35 per share. Mortgage new insurance written increased compared to the same quarter last year, while mortgage insuranc…
Artiva Biotherapeutics announced positive initial clinical data from its ongoing trials of AlloNK®, an allogeneic NK cell therapy combined with rituximab, showing a 71% ACR50 response rate in refractory rheumatoid arthritis patients with six months follow-up. The therapy demonstrated a favorable safety profile enabling outpatient administration in …
Indian equity markets ended the session lower on Friday, with the Nifty 50 falling 0.60% and the BSE Sensex 30 slipping 0.66%. Losses were concentrated in Public Sector Undertakings, Banking and Oil & Gas names. Market breadth favored decliners on both the NSE and BSE. A handful of large-caps including Titan Company, Apollo Hospitals and Asian Pain…
